Literature DB >> 4683155

Modification of levodopa effect by systemic decarboxylase inhibition.

H Mars.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4683155     DOI： 10.1001/archneur.1973.00490200039004

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  9 in total

Review 1.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 3.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 4.  Determination of levodopa by chromatography-based methods in biological samples: a review.

Authors:  Ruiqi Jiang; Jiayu Yang; Shenghui Mei; Zhigang Zhao
Journal:  Anal Sci       Date:  2022-06-17       Impact factor: 1.967

5.  Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

Authors:  U K Rinne; E Birket-Smith; E Dupont; E Hansen; M Hyyppä; R Marttila; B Mikkelsen; H Pakkenberg; J Presthus
Journal:  J Neurol       Date:  1975-12-02       Impact factor: 4.849

6.  Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.

Authors:  H Przuntek; D Welzel; E Blümner; W Danielczyk; H Letzel; H J Kaiser; P H Kraus; P Riederer; D Schwarzmann; H Wolf
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

7.  Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.

Authors:  R Katzenschlager; A Evans; A Manson; P N Patsalos; N Ratnaraj; H Watt; L Timmermann; R Van der Giessen; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

8.  Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

Authors:  Roberto Cilia; Janeth Laguna; Erica Cassani; Emanuele Cereda; Nicolò G Pozzi; Ioannis U Isaias; Manuela Contin; Michela Barichella; Gianni Pezzoli
Journal:  Neurology       Date:  2017-07-05       Impact factor: 9.910

Review 9.  Knowing Your Beans in Parkinson's Disease: A Critical Assessment of Current Knowledge about Different Beans and Their Compounds in the Treatment of Parkinson's Disease and in Animal Models.

Authors:  Michel Rijntjes
Journal:  Parkinsons Dis       Date:  2019-10-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.